Table 1 Patient characteristics
Units | Non-Dula (n = 38) | Dula (n = 38) | p | |
|---|---|---|---|---|
Age | Year | 68 ± 14 | 71 ± 9 | 0.21 |
Female | n (%) | 18 (47) | 17 (45) | 0.82 |
Weight | kg | 58 ± 10 | 56 ± 11 | 0.50 |
BMI | kg/m2 | 23.2 ± 3.7 | 21.9 ± 5.3 | 0.26 |
History of diabetes | n (%) | 24 (63) | 23 (61) | 0.82 |
Duration of diabetes | Year | 0 [0–14] | 0 [0–11] | 0.74 |
Observation period | Day | 31 [19–49] | 30 [16–48] | 0.99 |
Underlying disease | n (%) | |||
Autoimmune disease | 18 (47) | 17 (45) | 0.82 | |
Kidney disease | 8 (21) | 6 (16) | 0.55 | |
Dermatosis | 4 (11) | 5 (13) | 0.72 | |
Pulmonary disease | 3 (8) | 4 (11) | 0.69 | |
Hematologic disease | 2 (5) | 1 (3) | 0.56 | |
Hepatopathy | 2 (5) | 2 (5) | 1.00 | |
Neurological disease | 1 (3) | 3 (8) | 0.30 | |
Diet therapy | kcal/day | 1571 ± 221 | 1498 ± 179 | 0.14 |
SBP | mmHg | 124 ± 16 | 122 ± 16 | 0.46 |
DBP | mmHg | 72 ± 11 | 72 ± 10 | 0.99 |
HbA1c | % | 7.6 ± 2.0 | 7.6 ± 1.9 | 0.99 |
FBG | mg/dL | 156 [111–192] | 177 [116–238] | 0.27 |
Serum CPR | ng/mL | 2.6 [1.5–4.1] | 2.6 [1.5–4.0] | 0.98 |
Urinary CPR | μg/day | 46 [13–95] | 33 [11–49] | 0.31 |
TG | mg/dL | 121 [91–167] | 107 [86–156] | 0.43 |
LDL-C | mg/dL | 116 [101–151] | 97 [79–145] | 0.10 |
HDL-C | mg/dL | 48 [39–48] | 46 [38–59] | 0.83 |
Serum creatinine | mg/dL | 0.93 [0.65–2.24] | 0.79 [0.57–1.28] | 0.21 |
eGFR | mL/min /1.73 m2 | 49 [23–74] | 60 [45–85] | 0.14 |
ALT | U/L | 24 [14–39] | 16 [11–25] | 0.11 |
AST | U/L | 23 [16–30] | 19 [14–27] | 0.27 |
Amylase | U/L | 71 [43–102] | 69 [57–104] | 0.50 |
Lipase | U/L | 32 [18–60] | 39 [27–48] | 0.72 |